- Home
- BBN vs LXRX Comparison
BBN vs LXRX Comparison
Compare BBN & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBN | LXRX |
|---|---|---|
| Founded | 1983 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.0M | 996.7M |
| IPO Year | 2010 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BBN | LXRX |
|---|---|---|
| Price | $15.22 | $2.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.15 |
| AVG Volume (30 Days) | 122.2K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-01-2026 |
| Dividend Yield | ★ 6.90% | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $49,803,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $15.45 | $1.06 |
| 52 Week High | $17.45 | $2.68 |
Technical Indicators
Market Signals| Indicator | BBN | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 24.85 | 33.98 |
| Support Level | N/A | $2.01 |
| Resistance Level | $16.02 | $2.49 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 9.59 | 5.63 |
Price Performance
Historical ComparisonAbout BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest
BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation. The Trust seeks to achieve its investment objectives by investing in a portfolio of taxable municipal securities, including Build America Bonds (BABs), issued by state and local governments to finance capital projects such as public schools, roads, transportation infrastructure, bridges, ports and public buildings.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.